• Donated plasma benefits COVID-19 patients in small U.S. study

    8 days ago - By Reuters

    Patients with severe COVID-19 given plasma from someone who recovered from the disease were more likely to stabilize or need less oxygen support than other similar hospital patients, according to results of a small U.S. study released on Friday.
    Read more ...

     

  • Cuba credits two drugs with slashing coronavirus death toll

    8 days ago - By Reuters

    Communist-run Cuba said this week that use of two drugs produced by its biotech industry that reduce hyper-inflammation in seriously ill COVID-19 patients has sharply curbed its coronavirus-related death toll.
    Read more ...

     

  • Pregnant women with COVID-19 show placenta injury in small study

    8 days ago - By Reuters

    The placentas of 16 pregnant women found to have COVID-19 during routine testing at a Chicago hospital all showed evidence of injury, indicating that women infected with coronavirus may need close monitoring during pregnancy, researchers said on Friday.
    Read more ...

     

  • Drug touted by Trump to treat COVID-19 linked to higher death risk: study

    8 days ago - By Reuters

    The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk of death in hospitalized COVID-19 patients, a large study published on Friday showed.
    Read more ...

     

  • Beyond politics, gold-standard COVID-19 trials test malaria drug taken by Trump

    8 days ago - By Reuters

    In the fight against COVID-19, the decades-old anti-malarial drug hydroxychloroquine has become a political football, with U.S. President Donald Trump personally taking it and hailing it as a "game changer," to the derision of critics.
    Read more ...

     

  • Coronavirus vaccine safe in early trial; hydroxychloroquine may increase death risk

    8 days ago - By Reuters

    The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
    Read more ...

     

  • Early study of Covid-19 vaccine developed in China sees mixed results

    8 days ago - By STAT

    A Covid-19 vaccine candidate being developed by a Chinese drug maker appeared to induce an immune response in subjects, but also showed some concerning although not unexpected results.
    Data on the vaccine, made by CanSino Biologics, were published Friday in the Lancet , the first time Phase 1 trial data from any Covid-19 vaccine have been published in a scientific journal. The results are likely to be closely examined, particularly in Canada, which recently announced it would test the vaccine and produce it there if results of the early studies were positive.
    Read more ...

     

  • Large Study Finds No Benefit - and Potential Harm - in Using Hydroxychloroquine for COVID-19

    8 days ago - By Time

    In the largest observational study thus far investigating the drug hydroxychloroquine as a treatment for COVID-19, researchers found little evidence that it helps, and worrying evidence that the medication may cause harm.
    In a study published May 22 in the journal Lancet , scientists in the U.S. and Switzerland report on an analysis of more than 96,000 people hospitalized with confirmed COVID-19 in 671 hospitals on six continents. Nearly 15,000 patients were treated with one of the following: chloroquine (which is an older version of hydroxychloroquine), hydroxychloroquine, or either of...
    Read more ...